scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding scPharmaceuticals Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 33 | 37 | +4 |
| Shares | 15.9M | 15.9M | −53.1K (−0.3%) |
| Value | $80.0M | $90.1M | +$10.1M (+12.7%) |
New holders (6)
Institutions that held scPharmaceuticals Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Belvedere Trading LLC | 160,882 | $822.0K | 0.58% |
| Susquehanna International Group, LLP | 40,689 | $231.0K | 0.00% |
| Citadel Advisors LLC | 31,494 | $179.0K | 0.00% |
| FMR LLC | 889 | $5.00K | 0.00% |
| Group One Trading, L.P. | 654 | $4.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 100 | $1.00K | 0.00% |
Sold out (2)
Institutions that held scPharmaceuticals Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Jacobs Levy Equity Management, Inc | 81,891 | $411.0K |
| JPMorgan Chase & Co | 14 | $0 |